Form D · Pharmaceuticals

Whistler Medical Marijuana Corp

Whistler, A1 · CIK 0001621206

Offering snapshot reported Sep 17, 2018 · SEC filing

Reported sold
$135K
Offering amount: $135K
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 20, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 17, 2018Initial$135,017No comparison2SEC filing
May 3, 2018Initial$1,605,840No comparison3SEC filing
Apr 3, 2018Initial$419,667No comparison1SEC filing
Nov 15, 2017Initial$1,047,836No comparison2SEC filing
Oct 27, 2017Initial$404,107No comparison2SEC filing
May 25, 2017Initial$0No comparison2SEC filing
May 25, 2017Initial$0No comparison4SEC filing
Oct 20, 2014Amendment$1,502,872$588,358vs Oct 2, 20146SEC filing
Oct 2, 2014Initial$914,514No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-321460
US dollar amounts have been converted from Canadian dollars based on the 0.7654 Bank of Canada daily exchange rate in effect on 8-20-18.

Source: Form D, filed Sep 17, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christopher Pelz Director, Executive, Promoter

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1330 Alpha Lake Road, Unit 113
Whistler, A1, V0N 1B1